| 0 (0%) | 08-14 20:31 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 1.45 |
1-year : | 2.05 |
| Resists | First : | 1.24 |
Second : | 1.75 |
| Pivot price | 0.7 |
|||
| Supports | First : | 0.42 |
Second : | 0.35 |
| MAs | MA(5) : | 0.67 |
MA(20) : | 0.74 |
| MA(100) : | 2.08 |
MA(250) : | 6.14 |
|
| MACD | MACD : | -0.3 |
Signal : | -0.3  |
| %K %D | K(14,3) : | 43.1 |
D(3) : | 44.9 |
| RSI | RSI(14): 24.7 |
|||
| 52-week | High : | 19.89 | Low : | 0.42 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ GIPR ] has closed below the lower bollinger band by 33.7%. Although price has broken the lower band and a downside breakout is possible; the most likely direction for [ GIPR ] is to continue within current trading range. It is unclear right now based on current values. 82.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 8 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 1.27 - 1.28 | 1.28 - 1.29 |
| Low: | 0.42 - 0.42 | 0.42 - 0.42 |
| Close: | 0.49 - 0.49 | 0.49 - 0.49 |
Fri, 14 Aug 2026
Generation Income Properties (GIPR) sees 9.99% stake reported by Armistice Capital - Stock Titan
Wed, 12 Aug 2026
GIPR Q2'26 Earnings: EPS estimate is 2.40 USD - TradingView
Tue, 04 Aug 2026
Pfizer axes ex-Metsera obesity asset and GIPR prospect in quarterly clearout - Fierce Biotech
Wed, 29 Jul 2026
Antag Therapeutics doses first patient in Phase 2a of GIPR antagonist AT7687 for obesity - Dealroom
Mon, 27 Jul 2026
Solving the Mystery of Why Blocking and Stimulating a Brain Receptor Helps Weight Loss - Genetic Engineering and Biotechnology News
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 1 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 19.2 (%) |
| Held by Institutions | 5.4 (%) |
| Shares Short | 42 (K) |
| Shares Short P.Month | 5 (K) |
| EPS | -18.11 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -9.4 |
| Profit Margin | -102.1 % |
| Operating Margin | -11.7 % |
| Return on Assets (ttm) | -0.8 % |
| Return on Equity (ttm) | -20.8 % |
| Qtrly Rev. Growth | -8.4 % |
| Gross Profit (p.s.) | 8.56 |
| Sales Per Share | 11.44 |
| EBITDA (p.s.) | 4.1 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 1 (M) |
| Levered Free Cash Flow | 12 (M) |
| PE Ratio | -0.03 |
| PEG Ratio | 0 |
| Price to Book value | -0.06 |
| Price to Sales | 0.04 |
| Price to Cash Flow | 0.61 |
| Dividend | 0.38 |
| Forward Dividend | 0 |
| Dividend Yield | 79.5% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|